Retraction Note: Urinary Cross-linked N-telopeptides of Type I Collagen Levels in Patients with Rheumatoid Arthritis (Calcified Tissue International, (2003), 72, 4, (491-497), 10.1007/s00223-002-1024-7);Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis

Calcified Tissue International

Volumn 72, Issue 4, 2003, Pages 491-497

  Iwamoto, J ^a   Takeda, T ^a   Ichimura, S ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Disuse; Physical activity; Postmenopausal women; Premenopausal women; Rheumatoid arthritis; Urinary cross linked N telopeptides of type I collagen (NTx)

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 AMINOTERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; PEPTIDE; PYRIDINOLINE; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOCLAST; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINARY EXCRETION; URINE LEVEL;

EID: 0041767274     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-019-00632-y     Document Type: Erratum

References (42)

1. Haugeberg G, Uhlig T, Flach JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Results from 394 patients in the Oslo county rheumatoid arthritis register. Arthritis Rheum 43:522-530
2. Kroger H, Honkanen R, Saarikoski S, Alhave E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population-based study. Ann Rheum Dis 53:18-23
3. Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC (1995) The study of osteoporotic fractures research group. Rheumatoid arthritis and bone mineral density in elderly women. J Bone Miner Res 10:257-263
4. Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmar R, Ring F, Bhalla AK (1994) Bone mineral density in nonsteroid-treated early rheumatoid arthritis. Ann Rheum Dis 53:681-684
5. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 30:721-728
6. Martin JC, Munro R, Campbell MK, Reid DM (1997) Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 36:43-49
7. Laan RF, Buijs WC, Verbeek AL, Draad MP, Corstens LB, van de Putte LB, van Riel PL (1993) Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 52:21-26
8. Celiker R, Gokce-Kutsal Y, Cindas A, Ariyurek M, Renda N, Koray Z, Basgoze O (1995) Osteoporosis in rheumatoid arthritis: effect of disease activity. Clin Rheumatol 14:429-433
9. Laan RF, van Riel PL, van de Putte LB (1992) Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 51:826-832
10. Kalla AA, Meyers OL, Laubscher R (1995) Prevalence of metacarpal osteopenia in young rheumatoid arthritis patients. Clin Rheumatol 14:617-625
11. Buckley LM, Leib ES, Cartularo K, Vacek PM, Cooper SM (1995) Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 22:1055-1059
12. Butler RC, Davie MW, Worsfold M, Sharp CA (1991) Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheumatol 30:86-90
13. Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B (1998) Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25:2339-2344
14. Laan RF, van Riel PL, van Erning LJ, Lemmens JA, Ruijs LB, van de Putte LB (1992) Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol 31:91-96
15. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD (1995) Longitudinal study of hand bone densitometry in rheumatoid arthritis. Arthritis Rheum 38:1204-1210
16. Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
17. Devlin J, Lilley J, Gough A, Huissoon A, Holder R, Reece P, Perkins P, Emery P (1996) Clinical associations of dual-energy X-ray absorptiometry measurement of hand bone mass in rheumatoid arthritis. Br J Rheumatol 35:1256-1262
18. Magaro M, Tricerri A, Piane D, Zoli A, Serra F, Altomonte L, Mirone L (1991) Generalized osteoporosis in non-steroid-treated rheumatoid arthritis. Rheumatol Int 11:73-76
19. Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309-322
20. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, Nguyen T, Emery P (1998) Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25:1282-1289
21. Hein G, Franke S, Muller A, Brauning E, Eidner T, Stein G (1997) The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 16:167-172
22. Suzuki M, Takahashi M, Miyamoto S, Hoshino H, Hushida K, Miura M, Inoue T (1998) The effects of menopause status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Br J Rheumatol 37:653-658
23. Gough AK, Peel NF, Eastell R, Holder RL, Lilley J, Emery P (1994) Excretion of pyridinum crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 53:14-17
24. Kollerup G, Hansen M, Horslev-Petersen K (1994) Urinary hydroxypyridinum cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol 33:816-820
25. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193-198
26. Spector TD, James IT, Hall GM, Thompson PW, Perrett DJ, Hart DJ (1993) Increased levels of urinary collagen crosslinks in female with rheumatoid arthritis. Clin Rheumatol 12:240-244
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries NS, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association's 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
28. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662
29. Iwamoto J, Takeda T, Ichimura S (2002) Forearm bone mineral density in postmenopausal women with rheumatoid arthritis. Calcif Tissue Int 70:1-8
30. Al-Awadhi AM, Olusi SO, Al-Zaid NS, Prabha K, Al-Jarallah KH, Ahmed AH, Al-Salem I, Sedeqi H, Atteyah Y (1998) Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 16:569-572
31. Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K (1999) Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. J Rheumatol 26:1250-1256
32. Black D, Marabani M, Sturrock RD, Robins SP (1989) Urinary excretion of the hydroxypyridinum cross links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 48:641-644
33. Seibel MJ, Duncan A, Robins SP (1989) Urinary hydroxypyridinum crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 16:964-970
34. Robins SP (1995) Collagen crosslinks in metabolic bone disease. Acta Orthop Scand 66(suppl 26):171-175
35. Gineyts E, Garnero P, Delmas PD (2001) Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. Rheumatology (Oxford) 40:315-323
36. Iwamoto J, Takeda T, Ichimura S (2001) Relationships between physical activity and metacarpal cortical bone mass and bone resorption in hemiplegic patients. J Orthop Sci 6:227-233
37. Nierman DM, Mechanick JI (1998) Bone hyperresorption is prevalent in chronically critically ill patients. Chest 114:1122-1128
38. Scheld K, Zittermann A, Heer M, Herzog B, Mika C, Drammer C, Stehle P (2001) Nitrogen metabolism and bone metabolism markers in healthy adults during 16 weeks of bed rest. Clin Chem 47:1688-1695
39. Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM (2001) Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40:623-630
40. Lems WF, Gerrits MI, Jacobs JW, van Vugt RM, van Rijn JW, Bijlsma JW (1996) Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 55:288-293
41. Willing MC, Torner JC, Burns TL, Segar ET, Werner JR (1997) Determinants of bone mineral density in postmenopausal white Iowans. J Gerontol A Biol Sci Med Sci 52:M337-M342
42. Astbury C, Bird HA, McLaren AM, Robins SP (1994) Urinary excretion of pyridinum crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 33:11-15